These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8062527)

  • 1. Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin.
    O'Donovan CA; Fan-Havard P; Tecson-Tumang FT; Smith SM; Eng RH
    Diagn Microbiol Infect Dis; 1994 Feb; 18(2):105-9. PubMed ID: 8062527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of zinc bacitracin capsules versus placebo for enteric eradication of vancomycin-resistant Enterococcus faecium.
    Mondy KE; Shannon W; Mundy LM
    Clin Infect Dis; 2001 Aug; 33(4):473-6. PubMed ID: 11462182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium.
    Weinstein MR; Dedier H; Brunton J; Campbell I; Conly JM
    Clin Infect Dis; 1999 Aug; 29(2):361-6. PubMed ID: 10476743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of vancomycin-resistant Enterococcus faecium gastrointestinal tract colonization in antibiotic-treated mice.
    Dever LL; Handwerger S
    Microb Drug Resist; 1996; 2(4):415-21. PubMed ID: 9158812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.
    Linden PK; Pasculle AW; Manez R; Kramer DJ; Fung JJ; Pinna AD; Kusne S
    Clin Infect Dis; 1996 Apr; 22(4):663-70. PubMed ID: 8729206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin-resistant Enterococcus faecium in a long-term care facility.
    Brennen C; Wagener MM; Muder RR
    J Am Geriatr Soc; 1998 Feb; 46(2):157-60. PubMed ID: 9475442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colonization pattern of vancomycin-resistant Enterococcus faecium.
    Yamaguchi E; Valena F; Smith SM; Simmons A; Eng RH
    Am J Infect Control; 1994 Aug; 22(4):202-6. PubMed ID: 7985818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of vancomycin-resistant Enterococcus faecium infections with an investigational streptogramin antibiotic (quinupristin/dalfopristin): a report of fifteen cases.
    Dever LL; Smith SM; Dejesus D; Masurekar M; Patel D; Kaminski ZC; Johanson WG
    Microb Drug Resist; 1996; 2(4):407-13. PubMed ID: 9158811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of vancomycin resistant Enterococcus faecium from food.
    Wegener HC; Madsen M; Nielsen N; Aarestrup FM
    Int J Food Microbiol; 1997 Mar; 35(1):57-66. PubMed ID: 9081226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas.
    Moreno F; Grota P; Crisp C; Magnon K; Melcher GP; Jorgensen JH; Patterson JE
    Clin Infect Dis; 1995 Nov; 21(5):1234-7. PubMed ID: 8589148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model.
    Whitman MS; Pitsakis PG; DeJesus E; Osborne AJ; Levison ME; Johnson CC
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1526-30. PubMed ID: 8726031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and rapid control of a vancomycin-resistant Enterococcus faecium (VREF) outbreak in a renal transplant unit in Spain: The environment matters.
    Herrera S; Sorlí L; Pérez-Sáez MJ; Ruiz-Garbajosa P; Barrios C; Plasencia V; Montero M; Terradas R; Crespo M; Castells X; Cantón R; Pascual J; Horcajada JP
    Enferm Infecc Microbiol Clin; 2017 Jan; 35(1):5-11. PubMed ID: 27156245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort.
    Linden PK; Pasculle AW; McDevitt D; Kramer DJ
    J Antimicrob Chemother; 1997 May; 39 Suppl A():145-51. PubMed ID: 9511079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance profile of Enterococcus species isolated from intestinal tracts of hospitalized patients in Jimma, Ethiopia.
    Abamecha A; Wondafrash B; Abdissa A
    BMC Res Notes; 2015 Jun; 8():213. PubMed ID: 26036911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colonization with vancomycin-resistant enterococci in chronic hemodialysis patients.
    Roghmann MC; Fink JC; Polish L; Maker T; Brewrink J; Morris JG; Light PD
    Am J Kidney Dis; 1998 Aug; 32(2):254-7. PubMed ID: 9708609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for prolonged carriage of vancomycin-resistant Enterococcus faecium among patients in intensive care units: a case-control study.
    Yoon YK; Lee SE; Lee J; Kim HJ; Kim JY; Park DW; Sohn JW; Kim MJ
    J Antimicrob Chemother; 2011 Aug; 66(8):1831-8. PubMed ID: 21652622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and genotypic characterization of vancomycin-resistant Enterococcus faecium clinical isolates from two hospitals in Mexico: First detection of VanB phenotype-vanA genotype.
    Bocanegra-Ibarias P; Flores-Treviño S; Camacho-Ortiz A; Morfin-Otero R; Villarreal-Treviño L; Llaca-Díaz J; Martínez-Landeros EA; Rodríguez-Noriega E; Calzada-Güereca A; Maldonado-Garza HJ; Garza-González E
    Enferm Infecc Microbiol Clin; 2016; 34(7):415-21. PubMed ID: 26589756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outbreak of hospital-adapted clonal complex-17 vancomycin-resistant Enterococcus faecium strain in a haematology unit: role of rapid typing for early control.
    Deplano A; Denis O; Nonhoff C; Rost F; Byl B; Jacobs F; Vankerckhoven V; Goossens H; Struelens MJ
    J Antimicrob Chemother; 2007 Oct; 60(4):849-54. PubMed ID: 17650516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Synercid Emergency-Use Study Group.
    Moellering RC; Linden PK; Reinhardt J; Blumberg EA; Bompart F; Talbot GH
    J Antimicrob Chemother; 1999 Aug; 44(2):251-61. PubMed ID: 10473233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorhexidine gluconate (CHG) activity against clinical isolates of vancomycin-resistant Enterococcus faecium (VREF) and the effects of moisturizing agents on CHG residue accumulation on the skin.
    Frantz SW; Haines KA; Azar CG; Ward JI; Homan SM; Roberts RB
    J Hosp Infect; 1997 Oct; 37(2):157-64. PubMed ID: 9364264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.